Brind.

CMS Finalizes Global Benchmark for Drug Pricing Model

1 report, 1 independent Updated Mon 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The Centers for Medicare & Medicaid Services issued a Final Rule establishing the Global Benchmark for Efficient Drug Pricing Model, a new mandatory Medicare payment model. This model requires manufacturer rebates for certain drugs if their price exceeds an international benchmark. The rule limits applicability to four manufacturers, causing expected Medicare Part B savings to drop from $11.9 billion to $440 million.

From natlawreview.com

Why it matters

Some supportBrind's analysis of the reports

The GLOBE Model uses international pricing benchmarks based on countries with a real gross domestic product per capita at least 60 percent of the United States. The reference countries include Austria, Belgium, Czech Republic, Denmark, France, Germany, and the United Kingdom.

From natlawreview.com

Who's involved

  • AustriaReference country used to set the international pricing benchmark.
  • Czech RepublicReference country used to set the international pricing benchmark.
  • BelgiumReference country used to set the international pricing benchmark.
  • DenmarkReference country used to set the international pricing benchmark.

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • AustriaSpeculative

    Manufacturers might face changes in revenue due to the international pricing benchmark.

  • Czech RepublicSpeculative

    Manufacturers might face changes in revenue due to the international pricing benchmark.

  • BelgiumSpeculative

    Manufacturers might face changes in revenue due to the international pricing benchmark.

  • DenmarkSpeculative

    Manufacturers might face changes in revenue due to the international pricing benchmark.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped